- Home
- CTRM vs VTGN Comparison
CTRM vs VTGN Comparison
Compare CTRM & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRM | VTGN |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 24.1M |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CTRM | VTGN |
|---|---|---|
| Price | $2.13 | $0.54 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 72.2K | ★ 651.9K |
| Earning Date | 04-15-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $124.49 |
| Revenue Next Year | N/A | $353.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.66 | $0.43 |
| 52 Week High | $2.65 | $5.14 |
Technical Indicators
Market Signals| Indicator | CTRM | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 36.90 |
| Support Level | $1.95 | $0.43 |
| Resistance Level | $2.18 | $0.67 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 48.59 | 10.20 |
Price Performance
Historical ComparisonAbout CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.